The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization

Environmental Research

Volumn 133, Issue , 2014, Pages 424-430

  Vineis, Paolo ^a,b   Stringhini, Silvia ^c   Porta, Miquel ^d,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Human Genetics Foundation   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Diet; Environmental epigenomics; Environmental pollutants; Socioeconomic status; Trade; Transgenerational hazards

Indexed keywords

DIET; EARLY INTERVENTION; ENVIRONMENTAL CHANGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; LIFESTYLE; MENARCHE; MIGRATION; MORTALITY; NON COMMUNICABLE DISEASE; NOTE; PHYSICAL ACTIVITY; POLICY; POLLUTANT; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS; SOCIOECONOMICS;

DIET; ENVIRONMENTAL EPIGENOMICS; ENVIRONMENTAL POLLUTANTS; SOCIOECONOMIC STATUS; TRADE; TRANSGENERATIONAL HAZARDS;

DISEASE; ENVIRONMENT; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; INTERNATIONALITY;

EID: 84901386351     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.02.002     Document Type: Note

References (88)

1. Abdellatif M. Differential expression of microRNAs in different disease states. Circulation Res. 2012, 110:638-650.
2. Adler N.E., et al. Socioeconomic status and health. The challenge of the gradient. Am. Psychol. 1994, 49:15-24.
3. Alonso-Magdalena P., et al. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat. Rev. Endocrinol 2011, 7:346-353.
4. Arnold M., et al. Cancer risk diversity in non-western migrants to Europe: an overview of the literature. Eur. J. Cancer 2010, 46:2647-2659.
5. Balbus J.M., et al. Early-life prevention of non-communicable diseases. Lancet 2013, 381:3-4.
6. Barouki R., et al. Developmental origins of non-communicable disease: implications for research and public health. Environ. Health 2012, 11:42.
7. Baumberg B. World trade law and a framework convention on alcohol control. J. Epidemiol. Commun. Health 2010, 64:473-474.
8. Beaglehole R., et al. Measuring progress on NCDs: one goal and five targets. Lancet 2012, 380:1283-1285.
9. Ben-Shlomo Y., Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int. J. Epidemiol. 2002, 31:285-293.
10. Berkman L.F., Kawachi I. Social Epidemiology 2000, Oxford University Press, New York.
11. Borghol N., et al. Associations with early-life socio-economic position in adult DNA methylation. Int. J. Epidemiol. 2012, 41:62-74.
12. Bray F., et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012, 13:790-801.
13. Carroll J.E., et al. Early childhood socioeconomic status is associated with circulating interleukin-6 among mid-life adults. Brain Behav. Immunity 2011, 25:1468-1474.
14. Casals-Casas C., Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu. Rev. Physiol. 2011, 73:135-162.
15. Christensen B.C., Marsit C.J. Epigenomics in environmental health. Front. Genet. 2011, 2:84.
16. Cohen S., et al. Socioeconomic status is associated with stress hormones. Psychosom. Med. 2006, 68:414-420.
17. Crider K.S., et al. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Adv. Nutr. 2012, 3:21-38.
18. Espina C., et al. Environmental and occupational interventions for primary prevention of cancer: a cross-sectorial policy framework. Environ. Health Perspect. 2013, 121:420-426.
19. Feinberg A.P., Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 2004, 4:143-153.
20. Gallo V., et al. Social inequalities and mortality in Europe-results from a large multi-national cohort. PLoS One 2012, 7:e39013.
21. Gasull M. Relative effects of educational level and occupational social class on body concentrations of persistent organic pollutants in a representative sample of the general population of Catalonia, Spain. Environ. Int. 2013, 60:190-201.
22. Gianaros P.J., et al. Perigenual anterior cingulate morphology covaries with perceived social standing. Social Cogn. Affect. Neurosci. 2007, 2:161-173.
23. Gianaros P.J., et al. Potential neural embedding of parental social standing. Social Cogn. Affect. Neurosci. 2008, 3:91-96.
24. Gluckman P.D., et al. Towards a new developmental synthesis: adaptive developmental plasticity and human disease. Lancet 2009, 373:1654-1657.
25. Grun F., Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147:S50-S55.
26. Grun F., Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocrine Metab. Dis. 2007, 8:161-171.
27. Grun F., Blumberg B. Endocrine disrupters as obesogens. Mol. Cell. Endocrinol. 2009, 304:19-29.
28. Grynbaum M.M. Will soda restrictions help New York win the war on obesity?. BMJ 2012, 345:e6768.
29. Hajat A., et al. Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology 2010, 35:932-943.
30. Hawkes, C., et al., 2009. Globalization, trade and the nutrition transition. In: Globalization and Health: Pathways, Evidence and Policy. Ronald Labonté, Ted Schrecker, Corinne Packer and Vivien Runnels (Eds.), Routledge.
31. Heald A.H., et al. Marked differences in the IGF system that are associated with migration in comparable populations of Gujaratis living in Sandwell, UK, and Gujarat, India. Diabetologia 2005, 48:1756-1765.
32. Heijmans B.T., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:17046-17049.
33. Hertzman C., Boyce T. How experience gets under the skin to create gradients in developmental health. Annu. Rev. Public Health 2010, 31:329-347. (323p following 347).
34. Hoffman A.M., Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics 2011, 3:19-34.
35. Holmboe-Ottesen G., Wandel M. Changes in dietary habits after migration and consequences for health: a focus on South Asians in Europe. Food Nutr. Res. 2012, 56.
36. Hou L., et al. Environmental chemical exposures and human epigenetics. Int. J. Epidemiol. 2012, 41:79-105.
37. Huang C., et al. Early life exposure to the 1959-1961 Chinese famine has long-term health consequences. J. Nutr. 2010, 140:1874-1878.
38. Hult M., et al. Hypertension, diabetes and overweight: looming legacies of the Biafran famine. PLoS One 2010, 5:e13582.
39. Illner A.K., et al. Review and evaluation of innovative technologies for measuring diet in nutritional epidemiology. Int. J. Epidemiol 2012, 41:1187-1203.
40. Jacobson-Dickman E., Lee M.M. The influence of endocrine disruptors on pubertal timing. Curr. Opin. Endocrinol. Diabetes Obesity 2009, 16:25-30.
41. Jensen T.J., et al. Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis 2008, 29:1500-1508.
42. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
43. Jo W.J., et al. Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure. Toxicol. Appl. Pharmacol. 2009, 241:294-302.
44. Kim K.Y., et al. Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environ. Health Perspect. 2010, 118:370-374.
45. Krieger N. Embodiment: a conceptual glossary for epidemiology. J. Epidemiol. Commun. Health 2005, 59:350-355.
46. Lee D.H., et al. Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ. Health Perspect. 2009, 117:1799-1802.
47. Lillycrop K.A. Effect of maternal diet on the epigenome: implications for human metabolic disease. Proc. Nutr. Society 2011, 70:64-72.
48. Loucks E.B., et al. Life course socioeconomic position is associated with inflammatory markers: the Framingham Offspring Study. Social Sci. Med. 2010, 71:187-195.
49. Lyko F., et al. The honey bee epigenomes: differential methylation of brain DNA in queens and workers. PLoS Biol. 2010, 8:e1000506.
50. Manikkam M., et al. Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures. PLoS One 2012, 7:e31901.
51. Marinker M. Constructive Conversations About Health: Policy and Values 2006, Radcliffe Publishing.
52. Martinez L., et al. Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem. Int. 2011, 58:574-581.
53. McCredie M. Cancer epidemiology in migrant populations. Recent Results Cancer Res. 1998, 154:298-305.
54. McGuinness D., et al. Socio-economic status is associated with epigenetic differences in the pSoBid cohort. Int. J. Epidemiol. 2012, 41:151-160.
55. Meeker J.D. Exposure to environmental endocrine disruptors and child development. Arch. Pediatr. Adolescent Med. 2012, 166:952-958.
56. Menvielle G., et al. Occupational exposures contribute to educational inequalities in lung cancer incidence among men: evidence from the EPIC prospective cohort study. Int. J. Cancer 2010, 126:1928-1935.
57. Miller G.E., et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:14716-14721.
58. Miller G.E., et al. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol. Bull. 2011, 137:959-997.
59. Misra A., Ganda O.P. Migration and its impact on adiposity and type 2 diabetes. Nutrition 2007, 23:696-708.
60. Moodie R., et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet 2013, 381:670-679.
61. Mouritsen A., et al. The pubertal transition in 179 healthy Danish children: associations between pubarche, adrenarche, gonadarche, and body composition. Eur. J. Endocrinol. 2013, 168:129-136.
62. Ng S.W., Popkin B.M. Time use and physical activity: a shift away from movement across the globe. Obesity Rev. 2012, 13:659-680.
63. Nicoletto S.F., Rinaldi A. In the womb's shadow. The theory of prenatal programming as the fetal origin of various adult diseases is increasingly supported by a wealth of evidence. EMBO Rep. 2011, 12:30-34.
64. Popkin B.M. The shift in stages of the nutrition transition in the developing world differs from past experiences!. Public Health Nutr. 2002, 5:205-214.
65. Porta M., Zumeta E. Implementing the Stockholm treaty on persistent organic pollutants. Occup. Environ. Med. 2002, 59:651-652.
66. Raghupathy P., et al. Glucose tolerance, insulin resistance and insulin secretion in young south Indian adults: relationships to parental size, neonatal size and childhood body mass index. Diabetes Res. Clin. Pract. 2010, 87:283-292.
67. Ren X., et al. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ. Health Perspect. 2011, 119:11-19.
68. Rusiecki J.A., et al. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ. Health Perspect 2008, 116:1547-1552.
69. Rutter M. Achievements and challenges in the biology of environmental effects. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:17149-17153.
70. Rydin Y., et al. Shaping cities for health: complexity and the planning of urban environments in the 21st century. Lancet 2012, 379:2079-2108.
71. Sacerdote C., et al. Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study. Int. J. Epidemiol. 2012, 41:1162-1173.
72. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21:28-44.
73. Schalinske K.L., Nieman K.M. Disruption of methyl group metabolism by ethanol. Nutr. Rev. 2005, 63:387-391.
74. Sen A. Why health equity?. Health Econ. 2002, 11:659-666.
75. Stein R.A. Epigenetics and environmental exposures. J. Epidemiol. Commun. Health 2012, 66:8-13.
76. Steptoe A., et al. Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart 2007, 93:1567-1570.
77. Stringhini S., et al. Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 2012, 345:e5452.
78. Swedenborg E., et al. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J. Mol. Endocrinol. 2009, 43:1-10.
79. Tabish A.M., et al. Epigenetic factors in cancer risk: effect of chemical carcinogens on global DNA methylation pattern in human TK6 cells. PLoS One 2012, 7:e34674.
80. Tajuddin S.M., et al. Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. Environ. Health Perspect 2013, 121:650-656.
81. Tanner J.M. Trend towards earlier menarche in London, Olso, Copenhagen, the Netherlands and Hungary. Nature 1973, 243:95-96.
82. Taylor K.W., et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ. Health Perspect 2013, 121:774-783.
83. Thayer Z.M., Kuzawa C.W. Biological memories of past environments: epigenetic pathways to health disparities. Epigenetics: Official Journal of the DNA Methylation Society 2011, 6:798-803.
84. Tung J., et al. Social environment is associated with gene regulatory variation in the rhesus macaque immune system. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:6490-6495.
85. Vandenberg L.N., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Rev 2012, 33:378-455.
86. Vom Saal F.S., et al. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol. Cell. Endocrinol. 2012, 354:74-84.
87. Wagner K.H., Brath H. A global view on the development of non communicable diseases. Preventive Med. 2012, 54(Suppl):S38-S41.
88. Zhou X., et al. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol. Appl. Pharmacol. 2009, 236:78-84.